# Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip Prosthesis

> **NCT01218035** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 49 (actual)

## Conditions studied

- Hip Osteoarthritis

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT01218035
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2017-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01218035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01218035, "Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip Prosthesis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01218035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*